ANAVEX LIFE SCIENCES CORP. Deferred Tax Assets, Gross
ANAVEX LIFE SCIENCES CORP. (AVXL) had Deferred Tax Assets, Gross of $20.70 million as of 2025-09-30, per its 10-K/A filed 2026-08-28.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsGross · last filed 2026-08-28
- 2025-09-30: Deferred Tax Assets, Gross $20.70M.
- 2024-09-30: Deferred Tax Assets, Gross $15.10M.
- 2023-09-30: Deferred Tax Assets, Gross $7.20M.
| Period end | Deferred Tax Assets, Gross |
|---|---|
| 2025-09-30 | $20.70M 10-K/A · filed 2026-08-28 |
| 2024-09-30 | $15.10M 10-K/A · filed 2026-08-28 |
| 2023-09-30 | $7.20M 10-K · filed 2024-12-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |